Triple-negative breast cancer: promising prognostic biomarkers currently in developmentJasmine Sukumar, Nicole Williams, Kelly C. Gast et al.|Expert Review of Anticancer Therapy|2020Cited by 236
Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancerJasmine Sukumar, Sagar Sardesai, Leslie Appiah et al.|Breast Cancer Research and Treatment|2021Cited by 18
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancerRobert Wesolowski, William E. Carson, Andrew Stiff et al.|BMC Cancer|2020Cited by 16
Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancerNicole Williams, Robert Wesolowski, Dionisia Quiroga et al.|Therapeutic Advances in Medical Oncology|2023Cited by 14